{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:54:33Z","timestamp":1787867673055,"version":"build-2784847793"},"reference-count":38,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"unspecified","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2021,6,14]]},"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Venous thromboembolism (VTE) is an increasing concern in rheumatoid arthritis (RA) with little known about risk factors. We aimed to compare risk factors for unprovoked VTE and atherosclerotic cardiovascular disease (ASCVD) in patients with RA and to assess subsequent ASCVD risk after an unprovoked VTE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>People with RA participating in a US-wide longitudinal observational registry from 1998 to 2018 were assessed for incident unprovoked VTE (deep venous thrombosis and pulmonary emboli not associated with cancer, recent surgery, hospitalisation, fracture and pregnancy) and ASCVD (myocardial infarction and stroke) validated from hospital\/death records. Risk factors for VTE and ASCVD and the risk of ASCVD after an unprovoked VTE were determined using Cox proportional hazards models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During median (IQR) 4 (1.5\u20137) years of follow-up in 31 366 patients with RA, 539 unprovoked VTE and 1648 ASCVD events were identified. The adjusted models showed increased VTE and ASCVD risk with older age, male sex, comorbidities, prior fracture, worse disability, higher disease activity and glucocorticoids. Traditional cardiovascular disease risk factors were common in both ASCVD and VTE but only increased ASCVD risk with obesity as the exception (VTE HR (95%\u2009CI), 1.46 (1.13\u20131.87)) and ASCVD, 0.58 (0.50\u20130.68)). ASCVD risk doubled after an unprovoked VTE (HR (95%\u2009CI), 2.05 (1.43\u20132.95)).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings suggest that unprovoked VTE is mediated by inflammation of RA and may be considered a spectrum of pan-cardiovascular syndrome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rmdopen-2021-001618","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T11:57:05Z","timestamp":1625054225000},"page":"e001618","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":25,"title":["Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis?"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5423-393X","authenticated-orcid":false,"given":"Gulsen","family":"Ozen","sequence":"first","affiliation":[{"name":"Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Pedro","sequence":"additional","affiliation":[{"name":"FORWARD, The National Databank for Rheumatic Diseases, Wichita, Kansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Schumacher","sequence":"additional","affiliation":[{"name":"FORWARD, The National Databank for Rheumatic Diseases, Wichita, Kansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4042-0715","authenticated-orcid":false,"given":"Teresa","family":"Simon","sequence":"additional","affiliation":[{"name":"Physicians Research Center, LLC, Toms River, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5350-3934","authenticated-orcid":false,"given":"Kaleb","family":"Michaud","sequence":"additional","affiliation":[{"name":"Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA"},{"name":"FORWARD, The National Databank for Rheumatic Diseases, Wichita, Kansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,6,30]]},"reference":[{"key":"2025090313322382000_7.2.e001618.1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200726"},{"key":"2025090313322382000_7.2.e001618.2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx145"},{"key":"2025090313322382000_7.2.e001618.3","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1093\/eurheartj\/ehx251","article-title":"Inflammation, venous thromboembolism, and what we can do about it","volume":"39","author":"Glynn","year":"2018","journal-title":"Eur Heart J"},{"key":"2025090313322382000_7.2.e001618.4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.951236"},{"key":"2025090313322382000_7.2.e001618.5","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001392"},{"key":"2025090313322382000_7.2.e001618.6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1160\/TH05-04-0266","article-title":"The relationship between inflammation and venous thrombosis. A systematic review of clinical studies","volume":"94","author":"Fox","year":"2005","journal-title":"Thromb Haemost"},{"key":"2025090313322382000_7.2.e001618.7","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1055\/s-0036-1579642","article-title":"Thrombosis in autoimmune diseases: a role for immunosuppressive treatments?","volume":"42","author":"Silvestri","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"2025090313322382000_7.2.e001618.8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218419"},{"key":"2025090313322382000_7.2.e001618.9","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/art.39098","article-title":"Disease activity in rheumatoid arthritis and the risk of cardiovascular events","volume":"67","author":"Solomon","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025090313322382000_7.2.e001618.10","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.5.445"},{"key":"2025090313322382000_7.2.e001618.11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216761"},{"key":"2025090313322382000_7.2.e001618.12","first-page":"S100","article-title":"The National data bank for rheumatic diseases (NDB)","volume":"34","author":"Michaud","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2025090313322382000_7.2.e001618.13","doi-asserted-by":"publisher","DOI":"10.1002\/art.23811"},{"key":"2025090313322382000_7.2.e001618.14","unstructured":"Rural-Urban Commuting area codes. Available: https:\/\/www.ers.usda.gov\/data-products\/rural-urban-commuting-area-codes\/"},{"key":"2025090313322382000_7.2.e001618.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2007.06.002"},{"key":"2025090313322382000_7.2.e001618.16","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200265"},{"key":"2025090313322382000_7.2.e001618.17","first-page":"2410","article-title":"A composite disease activity scale for clinical practice, observational studies, and clinical trials: the patient activity scale (PAS\/PAS-II)","volume":"32","author":"Wolfe","year":"2005","journal-title":"J Rheumatol"},{"key":"2025090313322382000_7.2.e001618.18","doi-asserted-by":"crossref","unstructured":"Rubin DB . Multiple imputation in nonresponse for surveys. New York: Wiley, 1987.","DOI":"10.1002\/9780470316696"},{"key":"2025090313322382000_7.2.e001618.19","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000078468.11849.66"},{"key":"2025090313322382000_7.2.e001618.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02058.x"},{"key":"2025090313322382000_7.2.e001618.21","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1538-7836.2008.03062.x","article-title":"The relationship between unprovoked venous thromboembolism, age, and acute myocardial infarction","volume":"6","author":"Spencer","year":"2008","journal-title":"J Thromb Haemost"},{"key":"2025090313322382000_7.2.e001618.22","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10654-017-0277-4","article-title":"Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence","volume":"32","author":"Kunutsor","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"2025090313322382000_7.2.e001618.23","doi-asserted-by":"publisher","DOI":"10.1002\/art.33322"},{"key":"2025090313322382000_7.2.e001618.24","doi-asserted-by":"publisher","DOI":"10.1001\/2012.jama.11741"},{"key":"2025090313322382000_7.2.e001618.25","doi-asserted-by":"publisher","DOI":"10.1002\/art.38214"},{"key":"2025090313322382000_7.2.e001618.26","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.40798","article-title":"Comparative risk of venous thromboembolism in rheumatoid arthritis patients receiving tofacitinib versus those receiving tumor necrosis factor inhibitors: an observational cohort study","volume":"71","author":"Desai","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2025090313322382000_7.2.e001618.27","doi-asserted-by":"crossref","first-page":"539.e7","DOI":"10.1016\/j.amjmed.2014.11.025","article-title":"Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs","volume":"128","author":"Kim","year":"2015","journal-title":"Am J Med"},{"key":"2025090313322382000_7.2.e001618.28","doi-asserted-by":"publisher","DOI":"10.1002\/art.21628"},{"key":"2025090313322382000_7.2.e001618.29","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203380"},{"key":"2025090313322382000_7.2.e001618.30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ejh.12884","article-title":"Retrospective evaluation of venous thromboembolism: are all transient provoking events the same?","volume":"99","author":"Chua","year":"2017","journal-title":"Eur J Haematol"},{"key":"2025090313322382000_7.2.e001618.31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.709204"},{"key":"2025090313322382000_7.2.e001618.32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamacardio.2018.4537","article-title":"Cardiovascular risk factors associated with venous thromboembolism","volume":"4","author":"Gregson","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2025090313322382000_7.2.e001618.33","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024507"},{"key":"2025090313322382000_7.2.e001618.34","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.14.1624"},{"key":"2025090313322382000_7.2.e001618.35","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209954"},{"key":"2025090313322382000_7.2.e001618.36","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-010-0141-y"},{"key":"2025090313322382000_7.2.e001618.37","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211836"},{"key":"2025090313322382000_7.2.e001618.38","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi018"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2021-001618","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:32:31Z","timestamp":1756931551000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2021-001618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,6,30]]},"published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1136\/rmdopen-2021-001618"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2021-001618","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}